Tokyo, Dec. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060203) titled 'A systematic review of the functionality of "passionflower-derived flavonoids" for a function to mitigate temporary declines in vitality in healthy adults (updated version from 2022)' on Dec. 25.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Oryza Oil and Fat Chemical Co., Ltd.

Condition: Condition - The subjects were healthy adults (excluding those under 18 years old, pregnant women, and lactating women) Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to investigate whether the intake of passionflower-derived flavonoids effect function to mitigate temporary declines in vitality in healthy adults, including the latest RCTs. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - P-Participant: Participant The subjects were healthy adults (excluding those under 18 years old, pregnant women, and lactating women)

I-intervention: Intervention (food) characteristics Continuous intake of passionflower-derived flavonoids, Unlimited dosage forms, period and follow-up period.

C-Comparison: Comparison Placebo (The placebo's formulation is not specified)

O-Outcome: Outcome The primary outcome: QOL questionnaire (vitality) The secondary outcome: QOL questionnaire (other items)

S-Study design: Randomized parallel group controlled trials, randomized crossover trials, quasi-randomized parallel group controlled trials, quasi-randomized crossover trials, non-randomized parallel group controlled trials, non-randomized crossover trials or open trial Key exclusion criteria - The literature which does not meet PICOS, such as conference abstracts (conference proceedings) that are not original articles will be excluded.

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 12 Month 24 Day Anticipated trial start date - 2025 Year 12 Month 25 Day Last follow-up date - 2026 Year 01 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068856

Disclaimer: Curated by HT Syndication.